Back to search

Article

Defining muscle-invasive bladder cancer immunotypes by introducing tumor mutation burden, CD8+ T cells, and molecular subtypes

2020-12-11

Abstract excerpt

<title>Abstract</title> <p>Immunotherapy, especially anti-PD-1, is becoming a pillar of modern muscle-invasive bladder cancer (MIBC) treatment. However, the objective response rates (ORR) are relatively low due to the lack of precise biomarkers to select patients. Herein, the molecular subtype, tumor mutation burden (TMB), and CD8+ T cells were calculated by the gene expression and mutation profiles of MIBC patie...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f6a9b423-7f42-58b9-982b-901092a7352f
DOI
10.21203/rs.3.rs-54624/v2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Defining muscle-invasive bladder cancer immunotypes by introducing tumor mutation burden, CD8+ T cells, and molecular subtypesDOI 10.21203/rs.3.rs-54624/v2
Select a neighboring publication to make it the new centre.